You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

pm8002

Showing 1 - 8 of 8
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

SCLC Trial in Changchun (PM8002, Paclitaxel)

Recruiting
  • SCLC
  • Changchun, China
    Jilin Provincial Tumor Hospital
May 25, 2023

Malignant Tumor Trial in Shanghai (PM8002)

Recruiting
  • Malignant Neoplasm
  • PM8002
  • Shanghai, Shanghai, China
    Shanghai Orient Hospital
Jun 25, 2023

MPM Trial in Changchun (PM8002, Pemetrexed, Cisplatin)

Recruiting
  • MPM
  • PM8002
  • +3 more
  • Changchun, China
    Jilin Provincial Tumor Hospital
Jun 25, 2023

TNBC Trial in Shanghai (PM8002, nab-paclitaxel)

Recruiting
  • TNBC
  • Shanghai, China
    Fudan University Shanghai Cancer Center
Jun 25, 2023

Neuroendocrine Tumor Trial in Beijing (PM8002, FOLFIRI)

Recruiting
  • Neuroendocrine Neoplasm
  • Beijing, China
    Chinese PLA General Hospital
May 25, 2023

SCLC Trial (PM8002, Platinum, Atezolizumab)

Not yet recruiting
  • SCLC
  • PM8002
  • +3 more
  • (no location specified)
May 4, 2023

Hepatocellular Carcinoma Trial in Hangzhou (PM8002, FOLFOX regimen)

Recruiting
  • Hepatocellular Carcinoma
  • PM8002
  • FOLFOX regimen
  • Hangzhou, Zhejiang, China
    Cancer Hospital of The University of Chinese Academy of Sciences
May 19, 2023

NSCLC Trial (PM8002, Placebo, Carboplatin)

Not yet recruiting
  • NSCLC
  • PM8002
  • +3 more
  • (no location specified)
Feb 23, 2023